This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1991 Nov 9;303(6811):1147-8.

doi: 10.1136/bmj.303.6811.1147.

Avoiding autocannibalism

R J Ross, J P Miell, C R Buchanan

PMID: 1747603
PMCID: PMC1671509
DOI: 10.1136/bmj.303.6811.1147

Editorial

Avoiding autocannibalism

R J Ross et al. BMJ. 1991.

. 1991 Nov 9;303(6811):1147-8.

doi: 10.1136/bmj.303.6811.1147.

Authors

R J Ross, J P Miell, C R Buchanan

PMID: 1747603
PMCID: PMC1671509
DOI: 10.1136/bmj.303.6811.1147

No abstract available

PubMed Disclaimer

Similar articles

Protein metabolism and the use of growth hormone and insulin-like growth factor-I in the critically ill patient.
Carroll PV. Carroll PV. Growth Horm IGF Res. 1999 Dec;9(6):400-13. doi: 10.1054/ghir.1999.0133. Growth Horm IGF Res. 1999. PMID: 10629160 Review. No abstract available.
Whither growth hormone in the catabolic state of critical illness?
Van Den Berghe G. Van Den Berghe G. Growth Horm IGF Res. 1999 Dec;9(6):397-9. doi: 10.1054/ghir.1999.0132. Growth Horm IGF Res. 1999. PMID: 10629159 No abstract available.
Treatment with GH and IGF-1 in critical illness.
Teng Chung T, Hinds CJ. Teng Chung T, et al. Crit Care Clin. 2006 Jan;22(1):29-40, vi. doi: 10.1016/j.ccc.2005.09.003. Crit Care Clin. 2006. PMID: 16399018 Review.
Treatment with growth hormone and insulin-like growth factor-I in critical illness.
Carroll PV. Carroll PV. Best Pract Res Clin Endocrinol Metab. 2001 Dec;15(4):435-51. doi: 10.1053/beem.2001.0162. Best Pract Res Clin Endocrinol Metab. 2001. PMID: 11800516 Review.
Growth hormone and insulin-like growth factors in critical illness.
Gibson FA, Hinds CJ. Gibson FA, et al. Intensive Care Med. 1997 Apr;23(4):369-78. doi: 10.1007/s001340050343. Intensive Care Med. 1997. PMID: 9142574 Review. No abstract available.

See all similar articles

Cited by

Exogenous growth hormone: effects on the catabolic response to surgically produced acute stress and on postoperative immune function.
Vara-Thorbeck R, Guerrero JA, Rosell J, Ruiz-Requena E, Capitán JM. Vara-Thorbeck R, et al. World J Surg. 1993 Jul-Aug;17(4):530-7; discussion 537-8. doi: 10.1007/BF01655116. World J Surg. 1993. PMID: 8362531 Clinical Trial.
The role of insulin, growth hormone and IGF-I as anabolic agents in the critically ill.
Ross RJ, Rodriguez-Arnao J, Bentham J, Coakley JH. Ross RJ, et al. Intensive Care Med. 1993;19 Suppl 2:S54-7. doi: 10.1007/BF01708801. Intensive Care Med. 1993. PMID: 7508957 Review. No abstract available.
Effect of insulin-like growth factor-1 on the responses to and recognition of hypoglycemia in humans. A comparison with insulin.
Kerr D, Tamborlane WV, Rife F, Sherwin RS. Kerr D, et al. J Clin Invest. 1993 Jan;91(1):141-7. doi: 10.1172/JCI116163. J Clin Invest. 1993. PMID: 8423214 Free PMC article.
The development and reliability of the Royal College of General Practitioners' questionnaire for measuring senior house officers' satisfaction with their hospital training.
Hand CH, Adams M. Hand CH, et al. Br J Gen Pract. 1998 Jul;48(432):1399-403. Br J Gen Pract. 1998. PMID: 9800398 Free PMC article.

References

1. JPEN J Parenter Enteral Nutr. 1990 Sep-Oct;14(5):437-41 - PubMed
1. Surg Clin North Am. 1976 Oct;56(5):1073-90 - PubMed
1. Ann Surg. 1990 Oct;212(4):424-9; discussion 430-1 - PubMed
1. Ann Surg. 1987 Jul;206(1):56-61 - PubMed
1. Ann Surg. 1989 Oct;210(4):513-24; discussion 524-5 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central